Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.25 -4.35% 27.50 27.00 27.50 29.75 27.25 29.75 1,106,600 16:35:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -7.2 -4.5 - 56

Futura Medical Share Discussion Threads

Showing 16976 to 16999 of 17700 messages
Chat Pages: Latest  684  683  682  681  680  679  678  677  676  675  674  673  Older
DateSubjectAuthorDiscuss
12/7/2019
10:41
Resistance at 36.29 is broken will head will head to 43.0 soon
bag158s
12/7/2019
10:41
this time it will move above 40p nrxt near term tgt is 50-55p
ih_116147
12/7/2019
09:49
FYI... Barchart Technical Opinion STRONG BUY The Barchart Technical Opinion rating is a 96% Buy and ranks in the Top 1% of all short term signal directions. Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.
j777j
11/7/2019
12:17
Fum projected $1 billion peak sales. Cialis maker Icos was sold for $2.3 billion to Eli Lilly,on annual sales around $600 million.Eli Lilly paid that amount to secure the 50% joint venture on Cialis ,it did not already own. It means there could be considerable upside if trials are successful. Arguably the value of the med gel is far higher than what was in effect a mere Viagra clone. Fum have the biggest and most disruptive innovation in the ED market for two decades.
j777j
11/7/2019
10:35
Well I like your enthusiasm. And maybe you've managed to cheer the market a little bit. :)
brucie5
11/7/2019
10:26
Takeover or Big Partnership ? whatever comes the share price will explode higher ...Erectile dysfunction market is $5.6 BILLION and FUM unique ED gel will capture a large part of that market .Fair Value should be closer to £2 by now and higher on Phase 3 success .
ih_116147
08/7/2019
18:27
Well, in this market, let alone the world of ongoing clinical trials, potential is something that has to be severely risk adjusted. I would be happy with 60p.
brucie5
08/7/2019
12:41
By november they would have had 6 weeks to analyse the phase 3 trial data,so anytime after that. If results are great Liberum have 140p price target. Not often you can buy into something that technically could yield a 300% return 3 months. Gla and if anyone makes loads,please donate something to your favourite charity as token of gratitude.
j777j
08/7/2019
11:59
Doubled up. Looks over bought on the one hand, and yet... When are the next results due?
brucie5
08/7/2019
11:13
I would imagine the share price will levitate back towards the 60p levels as phase 3 results and the pain gel UK marketing approval edge ever closer. Gla
j777j
08/7/2019
09:08
one billion Mkt it has been said, 1% of 1 bn =1 ,000,000 10% profit 1,000,000 simple's Meerkat. BB
black bird
05/7/2019
19:27
Thanks for the correction :-0
ragnarr
05/7/2019
18:43
Also don't forget that LO bought a shed load at the 56p placing level.So they are not making that much.
j777j
05/7/2019
18:12
LO were rather too long in nanoco,so I guess needed to sell some winner to pay for losers. Lo do not have 203 million shares,that is the share capital of the co,actually 204 million. Lo own 30m out of 204m.
j777j
05/7/2019
16:24
yes exactly, sold 1.2% of their nearly 16% holding after making several hundred percent profit or their original investment.
guessing
05/7/2019
16:24
LO taking profits by default. Most likely fund is overweight and has to reduce.-
wantage
05/7/2019
16:09
sorry 204 and a bit mil
ragnarr
05/7/2019
16:08
Lombard Odier taken a bit of profit - explains the drop - still got 203m shares
ragnarr
05/7/2019
15:44
Great time to top-up / buy in. FUM has a near term share price target of 60p and after TPR100 approval and news on MED2005 this will be £1.40+
guessing
05/7/2019
15:31
Excellent opportunity to top up at the moment, it's a win win situation now. Those selling now are looking for a quick buck whereas it's an opportunity now to improve our averages, the last 2 weeks have shown how quick this will move, the situation hasn't changed, this will rocket up close to the trial results and those holding and topping up will be the winners
tiananmen
05/7/2019
14:40
No, has very strong safety profile. Bottoms up.
j777j
05/7/2019
14:31
Are there any side effects?For example do you have to wear a glove when applying the gel to stop your fingers from stiffening up?
kop202
05/7/2019
08:46
When one realises that Eli Lilly paid $2.3 billion for the remaining 50% of Cialis maker Icos,on top of an upfront payment of $75 million after only stage 2 trials,Futura's potential becomes obvious. Futura have hugely disruptive products here. A topical ED gel that beats the pants off the competition in efficacy,speed and safety. Topical pains gels that work up to 10 x faster than currently available products. The $90 million expected in upfront and milestones alone covers the market cap. Then 15% royalties will generate huge recurring revenues. Billion dollar opportunity here
j777j
04/7/2019
18:44
Why the sudden drop today?
huntie2
Chat Pages: Latest  684  683  682  681  680  679  678  677  676  675  674  673  Older
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191023 02:13:09